関連する実験動画
Updated: Jun 25, 2026
06:17
Depletion of Specific Cell Populations by Complement Depletion
Published on: February 5, 2010
ノーナン症候群における凝固因子の欠陥と異常出血
M Sharland1, M A Patton, S Talbot
1South West Thames Regional Genetics Service, St George's Hospital Medical School, London, UK.
Lancet (London, England)
|January 4, 1992
まとめ
ヌーナン症候群の患者は,固有の凝固経路の欠陥のためにしばしば出血の問題を経験します. これらの出血障害は,因子欠乏を含むもので,ヌーナン症候群の自己相性遺伝的関連性を示唆している.
科学分野:
- 遺伝学 遺伝学とは
- 血液学 ヘマトロジ
- 小児科は小児科です.
背景:
- ヌーナン症候群は,自己相性支配的疾患である.
- 主な特徴には,変形性顔,先天性心臓病,短身などがあります.
- 不正常な出血が患者で逸話的に報告されています.
研究 の 目的:
- ヌーナン症候群の患者に凝固因子欠乏症を調査する.
- 出血異常の発生率と性質を決定する.
- この状態における出血傾向の遺伝的根拠を探求する.
主な方法:
- ヌーナン症候群の72人 (37人の男性,35人の女性) を研究した.
- 異常な傷や出血の評価された病歴.
- 活性化された部分血栓プラスティン時間を含む凝固検査を行った.
- 固有の経路における特定の凝固因子欠陥を特定した.
主要な成果:
- 患者の65%が異常出血歴を報告した.
- 40%が長期にわたる活性化部分性血栓形成時間を示した.
- 50%が内在経路因子 (XI,XII,VIII) の欠陥を持っていた.
- 出血歴と因子欠乏症の間の相関関係が低いことが観察されました.
- ノーナン症候群の親戚にも同様の凝固欠陥が発見されました.
結論:
- ヌーナン症候群は,固有の経路の凝固因子欠乏症と関連しています.
- これらの出血異常は,凝固カスケードの自己体調節を示唆しています.
- 関連する遺伝的メカニズムを解明するためにさらなる研究が必要である.
関連する概念動画
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:29Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...